CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511958 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jacqueline Aparecida Torres und 8 weiteren Autor:innen. Beteiligte Einrichtung: International Research Center, A.C. Camargo Cancer Center, São Paulo 01508-010, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating, Lung Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pronon, Brazilian Health Ministry PRONON, São Paulo Research Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Circulating tumor cells (CTCs) and/or circulating tumor microemboli (CTM) from non-small cell lung cancer (NSCLC) patients may be a non-invasive tool for prognosis, acting as liquid biopsy. CTCs interact with platelets through the transforming growth factor-β/transforming growth factor-β receptor type 1 (TGF-β/TGFβRI) forming clusters. CTCs also may express the Cluster of Differentiation 47 (CD47) protein, responsible for the inhibition of phagocytosis, the “don’t eat me” signal to macrophages.
Objectives
To isolate, quantify and analyze CTCs/CTMs from metastatic NSCLC patients, identify TGFβRI/CD47 expression in CTCs/CTMs, and correlate with progression-free survival (PFS).
Methods
Blood (10 mL) was collected at two time-points: T1 (before the beginning of any line of treatment; T2 (60 days after initial collection). CTCs were isolated using ISET®. Immunocytochemistry was conducted to evaluate TGFβRI/CD47 expression.
Results
45 patients were evaluated. CTCs were observed in 82.2% of patients at T1 (median: 1 CTC/mL; range: 0.33–11.33 CTCs/mL) and 94.5% at T2 (median: 1.33 CTC/mL; 0.33–9.67). CTMs were observed in 24.5% of patients and significantly associated with poor PFS (10 months vs. 17 months for those without clusters; p = 0.05) and disease progression (p = 0.017). CTMs CD47+ resulted in poor PFS (p = 0.041). TGFβRI expression in CTCs/CTMs was not associated with PFS.
Conclusion
In this study, we observed that CTC/CTM from NSCLC patients express the immune evasion markers TGFβRI/CD47. The presence of CTMs CD47+ is associated with poor PFS. This was the first study to investigate CD47 expression in CTCs/CTM of patients with NSCLC and its association with poor PFS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Research Center, A.C. Camargo Cancer Center, São Paulo 01508-010, Brazil.
- Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo 01509-900, Brazil.
- Faculdade de Medicina de Marília, São Paulo 17519-030, Brazil.
- Translational Medicine Laboratory, Núcleo de Pesquisa e Ensino da Rede São Camilo, São Paulo 04014-002, Brazil.
ORCID-Profile: Jacqueline Aparecida Torres, Alexcia Camila Braun, Anna Paula Carreta Ruano
Förderung
- Pronon
- Brazilian Health Ministry PRONON
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- JAT
- APCR
- ACB
Zitieren
APA
Torres, J. A., Brito, A. B. C., Silva, V. S. E., Messias, I. M., Braun, A. C., Ruano, A. P. C., Buim, M. E. C., Carraro, D. M., & Chinen, L. T. D. (2023). CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511958
Vancouver
Torres JA, Brito ABC, Silva VSE, Messias IM, Braun AC, Ruano APC, et al. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511958
BibTeX
@article{Torres2023,
author = {Torres, Jacqueline Aparecida and Brito, Angelo Borsarelli Carvalho and Silva, Virgilio Souza E and Messias, Iara Monique and Braun, Alexcia Camila and Ruano, Anna Paula Carreta and Buim, Marcilei E C and Carraro, Dirce Maria and Chinen, Ludmilla Thomé Domingos},
title = {CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511958}
}
EUVIMED